Press "Enter" to skip to content

New patent expiration for Astrazeneca Pharms drug PULMICORT RESPULES

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Astrazeneca Pharms drug PULMICORT RESPULES

Annual Drug Patent Expirations for PULMICORT+RESPULES
Annual Drug Patent Expirations for PULMICORT+RESPULES

Pulmicort Respules is a drug marketed by Astrazeneca Pharms and is included in one NDA. It is available from one supplier. There are three patents protecting this drug and two Paragraph IV challenges.

Drug patent litigation for PULMICORT RESPULES.

The generic ingredient in PULMICORT RESPULES is budesonide. One supplier is listed for this compound. Additional details are available on the budesonide profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Copyright © DrugPatentWatch. Originally published at New patent expiration for Astrazeneca Pharms drug PULMICORT RESPULES
    Do NOT follow this link or you will be banned from the site!